Table: begin end state 1 25 non-cytoplasmic 26 48 transmembrane 49 57 cytoplasmic 58 81 transmembrane 82 83 cytoplasmic 84 88 non-cytoplasmic 89 132 transmembrane 133 151 non-cytoplasmic 152 171 transmembrane 172 178 cytoplasmic 179 201 transmembrane 202 212 non-cytoplasmic 213 232 transmembrane 233 251 cytoplasmic 252 275 transmembrane 276 329 non-cytoplasmic 330 352 transmembrane 353 380 cytoplasmic 381 400 transmembrane 401 405 non-cytoplasmic 406 426 transmembrane 427 437 cytoplasmic 438 457 transmembrane 458 463 non-cytoplasmic 464 481 transmembrane 482 512 cytoplasmic
Input: >Ga0059261_1053 MIFGRVKPLDAILATAEKKSLHRSLGAFQLTMLGIGAVIGTGIFVLTAEAAQKAGPGMML SFVIAGVVCAVAALCYAEMAAMVPVSGSAYTYSYAVMGELIAWMVGWALILEYAVAAGAV SVGWSGYVVGLIENAFALDIPDALVRGPYDGGIINLPAMLIAGLVTWLLVIGTKESAFVN SVLVLVKVSALSLFIILAIPVMNMQNFEPFSPLGFAGVSAAAASIFFAYVGFDAVSTAAE ETKNPQRNMPIGLIGSLAICTIFYLLVAAGVIGSVGAQPILGPDGAALPPGSTELTKACV ETAAATGKEAVVCSKEALAWTLREIGWPQIGNLIGLAAGLALPSVILMMMFGQTRIFFVM SRDGLLPAVFSKVHPKFHTPHVITILTGVFVALFAAFFPVGKLADISNSGTLFAFAAVSI AVLVLRRTDPDRKRPFRTPLIIITAPIAILGCAYLFYSLGHDTKMMFVGWAALGLLVYFG YSRRKSHVGRGIVETPEHEAYQELDPPVPGTH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server